在CHRONICLE研究中,严重喘和临床相关过敏患者的生物学结果
Bradley E Chipps1, Warner W Carr2, Reynold A Panettieri3
1Capital Allergy & Respiratory Disease Center, Sacramento, Calif.
The journal of allergy and clinical immunology. Global
|December 1, 2025
概括
生物疗法显著减少了严重喘和过敏的成年人的喘恶化,急诊室访问和住院治疗. 这些改善在不同的生物类型中观察到,突出显示了它们在治疗过敏性喘方面的有效性.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘往往与经过临床确认的过敏并存,这些过敏会加剧症状.
- 关于过敏引起的严重喘患者的生物疗法有效性的数据有限.
- 单克隆抗体 (mAb) 生物药物已被批准用于严重的喘,但它们对过敏恶化的影响需要进一步研究.
研究的目的:
- 评估生物疗法对严重喘和确诊过敏的成年人喘恶化的影响.
- 为了比较喘恶化率,急诊室 (ED) 访问率和生物启动前后住院率.
- 在过敏性喘患者中评估不同生物亚组的结果.
主要方法:
- 观察性研究 (CHRONICLE) 美国成年人患有严重喘,由次专家治疗.
- 包括临床医生确认的临床相关过敏和定期暴露于过敏原的患者.
- 在生物启动之前和之后的6个月内,加剧症,急救诊所和住院治疗的年均比率.
主要成果:
- 分析包括214名确诊过敏和定期暴露于过敏原的患者.
- 生物启动导致了显著的减少:喘恶化61%,ED访问55%,住院75%.
- 抗IL-4受体/抗胸腺性 stromal lymphopoietin生物药物 (73%的减少) 减少最为明显.
结论:
- 生物疗法有效地减少了严重喘和临床相关过敏的成年人的恶化,ED访问和住院治疗.
- 在各种生物子组中观察到生物制剂的益处.
- 这些发现支持使用生物药物来治疗严重过敏性喘.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:24Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K